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Abstract A methodology that would allow for compari-
son of charges across institutions has not been developed
for catheterization in congenital heart disease. A single
institution catheterization database with prospectively
collected case characteristics was linked to hospital charges
related and limited to an episode of care in the catheteri-
zation laboratory for ﬁscal years 2008–2010. Catheteriza-
tion charge categories (CCC) were developed to group
types of catheterization procedures using a combination of
empiric data and expert consensus. A multivariable model
with outcome charges was created using CCC and addi-
tional patient and procedural characteristics. In 3 ﬁscal
years, 3,839 cases were available for analysis. Forty cath-
eterization procedure types were categorized into 7 CCC
yielding a grouper variable with an R
2 explanatory value of
72.6 %. In the ﬁnal CCC, the largest proportion of cases
was in CCC 2 (34 %), which included diagnostic cases
without intervention. Biopsy cases were isolated in CCC 1
(12 %), and percutaneous pulmonary valve placement
alone made up CCC 7 (2 %). The ﬁnal model included
CCC, number of interventions, and cardiac diagnosis
(R
2 = 74.2 %). Additionally, current ﬁnancial metrics such
as APR-DRG severity of illness and case mix index dem-
onstrated a lack of correlation with CCC. We have devel-
oped a catheterization procedure type ﬁnancial grouper that
accounts for the diverse case population encountered in
catheterization for congenital heart disease. CCC and our
multivariable model could be used to understand ﬁnancial
characteristics of a population at a single point in time,
longitudinally, and to compare populations.
Keywords Resource utilization  RVU  Congenital heart
disease  Catheterization  Outcomes
Introduction
Congenital heart disease (CHD) accounts for a substantial
amount of health care spending in the USA, with acute care
expenditures estimated to be 6 billion dollars annually [11,
13, 14]. This large amount of healthcare expenditures is the
result of the variable anatomical and physiological anom-
alies seen in these patients, the requirement for multiple
hospitalizations for surgical and interventional therapies,
and lifelong follow-up with multidisciplinary medical
professionals [11]. Marelli et al. [8] in a study of the
population in Quebec over the past several decades showed
that mortality rates have decreased for patients with CHD.
As CHD patients’ life expectancy increases so does the
prevalence of CHD in the general population, leading to a
greater need to understand the ﬁnancial characteristics of
this diverse population so that potential areas to reduce and
standardize charges are identiﬁed.
We hypothesized that examining charges derived from
Current Procedural Terminology (CPT) billing codes of
catheterization procedures would provide a more accurate
assessment of patient resource utilization than widely used
current ﬁnancial metrics such as the All Patient Reﬁned
Diagnosis Related Groups (APR-DRG) diagnostic classiﬁ-
cation system, severity of illness (SOI), and case mix index
(CMI). Recent analysis has shown that the APR-DRG sys-
tem inaccurately classiﬁes patients admitted for congenital
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DOI 10.1007/s00246-014-0994-3heart surgery, which may have an impact on the accuracy of
outcome reporting and resource allocation planning [10].
We sought to create a procedure type ﬁnancial grouper as
well as consider other clinical or procedural characteristics
known a priori to predict resource utilization using charges
in CHD populations undergoing cardiac catheterization.
Total procedure-related values based on CPT codes were
chosen as the outcome for resource utilization to provide
generalizability to other institutions as procedures are gen-
erally billed based on CPT codes.
Methods
The study methods were reviewed and approved by the
Institutional Review Board at Children’s Hospital Boston.
Database Source
Our catheterization laboratory reporting and billing data-
base include patient and procedural characteristics on all
procedures performed at Children’s Hospital Boston. Hos-
pital charges were matchedto all catheterization cases in the
clinical database. As total hospital charges for the majority
of catheterization cases may reﬂect other aspects of care
unrelated to the catheterization procedure, such as elective
and surgical interventions during the same hospitalization,
the outcome charges chosen by the group were total pro-
cedure-related values from the catheterization laboratory,
comprising of procedure codes (CPT with associated
charge), supplies, and recovery-related expenses. Recov-
ery-related expenses were expenses accumulated during the
patient’s recovery and observation time in the catheteriza-
tion laboratory department and excluded any other aspects
of in-hospital care, such as recovery time as an inpatient in
the Intensive Care Unit or general ﬂoor. Cases were linked
to an APR-DRG Version 20.0 value based on International
Classiﬁcation of Diseases, 9th revision, Clinical Modiﬁca-
tion (ICD-9-CM) procedure and diagnosis codes assigned in
the reporting and billing database.
Population
All cases classiﬁed as diagnostic, interventional, or biopsy
only were identiﬁed in the catheterization database and
included. Few common case types such as hybrids or cases
recorded as pericardiocentesis, pleuracentesis, or ﬂuoros-
copy only were excluded. The ﬁscal years 2008, 2009, and
2010 comprised the cohort. In the data set, 3,978 cases met
inclusion criteria of which 3,940 cases were matched in the
hospital database and of these 3,883 had an associated
charge recorded. Outliers with total charges less than
$10,000 and greater than $100,000 were examined in
detail. Based on this review, we excluded 16 cases with
incomplete billing and a total charge less than $5,000
(N = 3,867) and excluded 28 with no procedure charge for
a ﬁnal cohort of 3,839 cases.
Predictor Variables
We considered both patient and procedural characteristics
as potential predictor variables of the outcome charges.
Patient characteristics included the following: age, weight,
diagnosis, genetic syndrome, non-cardiac problem, previ-
ous catheterization, previous catheterization within
30 days, previous surgery, previous surgery within
30 days, admit source, mechanical circulatory support
including ECMO, continuous supportive intravenous (IV)
medications including vasoactive medications and ino-
tropes, intubation status, known vascular occlusion, and
indicators of hemodynamic vulnerability. Procedural
characteristics included the following: year of procedure,
case type (diagnostic, interventional, or biopsy only),
intervention type (balloon angioplasty, valvotomy, stent
placement, stent redilation, device implant, or coil
implant), number of interventions, and procedure type risk
category as designated by Catheterization for Congenital
Heart Disease Adjustment for Risk Method (CHARM) [2].
Development of Procedure Types and Catheterization
Charge Categories (CCC)
Since cardiac catheterization for CHD includes a wide
variety of case types, a multidisciplinary panel comprising
of the authors was established to develop procedure types
(n = 35) with empiric analysis followed by expert con-
sensus to group case types into categories with similar
charges. Charges were summarized by mutually exclusive
catheterization procedure types. To identify procedure
types with potential modifying factors, procedure types
were ranked from high to low distribution of charges
within the procedure type designation. The procedure types
were grouped into different combination of numbers of
categories according to empiric similarity in order to
minimize the variation within a group while maximizing
discrimination between groups.
Statistical Methods and Development
of the Multivariable Model
Patient and procedural characteristics were summarized by
median and interquartile range charges. The coefﬁcient of
determination (R
2) was calculated by univariate and mul-
tivariable linear regression models for the outcome char-
ges. A multivariable model was built using stepwise
forward regression for the outcome charges to normalize
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\1 month 227 (6) 26,843 17,136 33,839 \0.001 0.029
C1 month,\1 year 659 (17) 32,351 20,538 44,909
C1 year,\5 years 913 (24) 33,540 19,617 45,392
C5 years,\18 years 1,340 (35) 22,846 15,782 37,942
C18 years 700 (18) 23,246 16,692 37,727
Weight (kg)
\4 321 (8) 28,759 17,646 35,660 \0.001 0.034
4–9 830 (22) 32,868 20,350 45,038
10–19 815 (21) 33,787 19,818 45,769
C20 1,872 (49) 22,636 15,834 37,134
Diagnosis
a
No structural defects 150 (4) 16,676 11,949 23,039 \0.001 0.298
Heart transplant 743 (19) 15,126 13,335 20,632
Isolated defects 635 (17) 31,337 21,636 36,807
Pulmonary hypertension 107 (3) 16,784 10,086 21,724
Complex two ventricle 1,491 (39) 34,235 21,006 48,927
Single ventricle 711 (19) 37,014 24,004 50,281
Genetic syndrome
b
Yes 502 (13) 30,046 18,516 43,876 0.02 0.001
No 3,330 (87) 27,896 17,621 41,025
Non-cardiac problem
c
Yes 1,372 (36) 25,696 17,448 40,602 0.03 0.002
No 2,454 (64) 29,195 18,018 41,577
Previous catheterization
Yes 2,058 (54) 35,819 21,406 50,322 \0.001 0.151
No 1,781 (46) 20,605 15,069 31,832
Previous catheterization within 30 days
Yes 207 (5) 34,474 21,785 54,199 \0.001 0.008
No 3,632 (95) 27,573 17,676 40,899
Previous surgery
Yes 2,064 (54) 35,099 21,340 48,898 \0.001 0.143
No 1,775 (46) 20,549 14,854 32,239
Previous surgery within 30 days
Yes 229 (6) 29,451 18,708 43,172 0.11 0.001
No 3,610 (94) 27,955 17,757 41,173
Admit source
Elective 3,038 (79) 28,269 18,037 41,754 0.04 0.002
Non elective 801 (21) 28,046 17,103 40,068
Mechanical circulatory support
d
Yes 88 (2) 28,323 17,408 39,615 0.98 0.000
No 3,724 (97) 28,266 17,850 41,305
Continuous supportive IV medications
e
Yes 421 (11) 29,451 18,142 41,446 0.15 0.001
No 3,392 (88) 27,896 17,731 41,213
Intubation status
f
Spontaneous 1,393 (36) 20,216 15,094 32,173 \0.001 0.101
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123for skewed distributions. Starting with CCC, all of the
patient and procedural characteristics were considered for
inclusion in the multivariable model until no additional
explanatory value could be found by adding a variable to
the model. The proportion of cases in each of the 4 sub-
classes of APR-DRG SOI was summarized by CCC, and
the weighted mean SOI was calculated by CCC. Geometric
mean APR-DRG CMI was calculated by CCC.
Results
Patient Characteristics
Charges were summarized according to patient characteris-
tics based on the ﬁnal cohort of 3,839 cases in Table 1. The
majorityofthepatientswasbetweentheagesof1–18(82 %)
and had a diagnosis of complex CHD with two ventricles
(39 %) or single ventricle physiology (19 %). For most
cases, the patient had a previous catheterization (54 %) or a
previous surgery (54 %). In univariate analysis although
diagnosis alone explained some variation in charge
(R
2 = 27.2 %), we noted that, as a population, the majority
of patient characteristics that anecdotal experience suggests
may be important in determining the intensity of resources
needed to perform a case, such as age (R
2 = 2.9 %), admit
source (R
2 = 0.2 %), intubation status (R
2 = 10.1 %),
continuous supportive IV medications (R
2 = 0.1 %), and
indicators of hemodynamic vulnerability (R
2 = 2.4 %), did
not individually explain the variability in charges despite
having a signiﬁcant association with charge (P\0.01).
Procedural Characteristics
Charges were summarized according to procedural charac-
teristics(Table 2).About57 %ofcaseswereinterventional,
with balloon angioplasty (27 %) the most frequent inter-
vention performed. The majority of cases required two or
fewerinterventions(82 %).Theincreasedmedianchargeby
year of catheterization procedure is mostly due to an
increase in the number of percutaneous pulmonary valve
placementsperformedoverthethreeﬁscalyears2008,2009,
and 2010. In univariate analysis, case type (R
2 = 54.4 %),
number of interventions (R
2 = 49.8 %), and procedure type
risk category (R
2 = 49 %) individually demonstrated a
moderate relationship with the variability in charges.
However, examining intervention type individually did not
explainvariabilityinchargesalthougheachhadasigniﬁcant
association with charge (P\0.01).
Procedure Types
For some procedure types, such as pulmonary artery
angioplasty, discrimination improved when stratiﬁed by the
number of interventions, while for other procedure types,
such as pulmonary valve dilation, the number of inter-
ventions had less effect. Procedure types that led to
improved discrimination were stratiﬁed into the number of
interventions, leading to the ﬁnal 40 procedure types based
on expert clinical consensus and empiric analysis summa-
rized in Table 3.
Catheterization Charge Categories
With the procedure types deﬁned, the multidisciplinary
panel looked for a categorization number that had face
validity, with the ﬁnal CCC containing 7 categories as
summarized in Table 3. Although similar in charges to
diagnostic cases, biopsy cases were forced as a separate
group in the CCC for better potential future generaliz-
ability of the ﬁnal model when applying to institutions
that perform diagnostic, but few if any biopsy cases.
Table 1 continued
N (%) Median ($) Percentiles P value R
2
25th 75th
Prior to transfer 507 (13) 31,079 18,794 43,262
Before case 1,886 (49) 33,565 20,476 47,682
During case 40 (1) 37,359 18,727 53,733
Known vascular occlusion
Yes 507 (13) 30,548 18,660 48,133 0.002 0.003
No 3,332 (87) 27,914 17,716 40,716
Indicators of hemodynamic vulnerability
0 2,055 (54) 23,416 16,050 36,775 \0.001 0.024
1 1,018 (27) 31,416 19,123 45,050
C2 766 (20) 32,376 19,274 47,319
a Not entered N = 2;
b Not entered N = 7;
c Not entered N = 13;
d Not entered N = 27;
e Not entered N = 26;
f Not entered N = 13
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123Percutaneous pulmonary valve placement was forced into
a separate category for similar reasons. Additionally, the
total procedure-related charges for percutaneous pulmon-
ary valve placement, for which a high percentage is
associated with the cost of the valve device, were sig-
niﬁcantly higher than those associated with any other
procedure type.
The distribution of cases by CCC and the median and
interquartile range of associated charges by CCC are
shown in Fig. 1. The largest proportion of cases were
ranked in CCC 2 (34 %), containing mostly diagnostic
cases without intervention. A summary of univariate
comparison of catheterization charges by CCC is detailed
in Table 4, with a statistically signiﬁcant p value for all
categories (P\0.01). The univariate linear regression
model for the outcome charges demonstrated a moderately
strong relationship (R
2 = 72.6 %) between variability in
charges by CCC.
Table 2 Summary of charges
for catheterization by
procedural characteristics
a No category N = 29




2008 1,238 (32) 25,952 16,584 38,219 \0.001 0.007
2009 1,363 (36) 28,854 18,454 42,839
2010 1,238 (32) 30,001 18,211 41,734
Case type
Diagnostic 915 (24) 18,180 16,021 20,281 \0.001 0.544
Interventional 2,196 (57) 38,084 31,264 51,303
Biopsy 728 (19) 15,059 13,253 20,468
Balloon angioplasty
Yes 1,021 (27) 43,895 33,830 57,876 \0.001 0.255
No 2,818 (73) 21,086 15,899 33,844
Valvotomy
Yes 242 (6) 34,947 31,457 40,980 \0.001 0.017
No 3,597 (94) 25,822 17,394 41,270
Stent placement
Yes 497 (13) 47,745 37,988 62,663 \0.001 0.154
No 3,342 (87) 23,396 16,868 36,682
Stent redilation
Yes 262 (7) 45,456 34,109 61,780 \0.001 0.061
No 3,577 (93) 25,698 17,353 39,725
Device implant
Yes 348 (9) 35,161 30,542 48,147 \0.001 0.028
No 3,491 (91) 25,545 17,183 40,731
Coil implant
Yes 445 (12) 47,199 37,130 61,359 \0.001 0.120
No 3,394 (88) 23,801 16,972 37,446
Number of interventions
None 937 (24) 18,206 15,984 20,315 \0.001 0.498
1 1,730 (45) 24,309 15,374 33,611
2 493 (13) 40,980 34,491 48,976
3 283 (7) 49,344 41,211 61,501
4 184 (5) 55,190 47,080 67,397
C5 212 (6) 61,731 49,073 72,145
Procedure type risk category
a
1 1,403 (36) 16,764 13,785 20,419 \0.001 0.490
2 930 (24) 31,418 22,369 36,875
3 883 (23) 39,251 30,848 53,035
4 594 (16) 45,409 36,280 59,944
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Heart biopsy after transplant 451 13,880 12,744 15,213
Category 2
Heart biopsy and diagnostic catheterization 990 18,243 15,909 20,478
Heart biopsy and coronary angiography 263 20,860 16,800 22,847
Diagnostic catheterization including transseptal puncture 43 23,018 19,744 25,075
Category 3
PDA device or coil closure 86 27,123 21,457 32,508
Atrial septum stent, dilation, or septostomy 62 28,961 22,155 40,712
PDA stent 4 28,439 27,304 31,322
Aorta dilation and/or stent (one intervention) 69 29,121 26,482 32,778
Aorta stent redilation 32 29,515 27,829 32,954
Pulmonary valvotomy (isolated intervention) 95 31,982 29,421 34,439
RVOT dilation and/or stent (no PA angioplasty or stent) (one intervention) 58 32,829 30,110 35,854
Proximal or distal right or left PA angioplasty and/or stent (excluding RVOT intervention) (one
intervention)
116 32,868 29,380 37,600
Category 4
Systemic vein dilation or stent 72 33,007 25,069 42,564
ASD or PFO closure (isolated intervention) 164 33,696 30,790 36,754
Aortic valvotomy (isolated intervention) 79 35,453 32,849 38,314
Coil/device systemic collateral (one intervention) 62 35,864 32,512 39,693
Systemic pulmonary shunt dilation or stent 16 37,746 28,365 47,257
Fenestration device closure (isolated intervention) 21 36,197 34,296 37,772
Coronary ﬁstula closure 6 38,282 35,819 39,596
Systemic artery angioplasty and/or stent (not aorta) 22 40,210 27,898 46,423
RVOT dilation and/or stent and proximal or distal right or left PA angioplasty and/or stent (two
interventions)
34 37,936 35,168 45,702
Fontan bafﬂe dilation 21 36,643 32,903 43,554
Category 5
RVOT dilation and/or stent (no PA angioplasty or stent) (plus at least one additional intervention) 37 43,702 34,967 48,210
Any pulmonary vein dilation and/or stent intervention 105 41,032 35,017 48,844
Aortic valvotomy (plus at least one additional intervention) 7 41,530 29,957 57,017
Proximal or distal right or left PA angioplasty and/or stent (excluding RVOT intervention) (two
interventions)
124 41,870 36,338 48,759
Aorta dilation and/or stent (plus at least one additional intervention) 53 42,822 37,652 48,386
Systemic collateral coil or device closure (plus at least one additional intervention) 122 42,859 37,130 54,854
Pulmonary valvotomy (plus at least one additional intervention) 7 46,151 39,433 52,986
Systemic venous collateral coil or device closure 24 40,142 36,733 52,169
Mitral valvotomy 24 43,129 40,464 52,788
RVOT dilation and/or stent and proximal or distal right or left PA angioplasty and/or stent (three
interventions)
32 49,014 40,553 56,045
VSD device placement 15 44,904 42,908 53,466
Systemic pulmonary collateral dilation or stent 4 49,382 39,240 59,163
Category 6
Proximal or distal right or left PA angioplasty and/or stent (excluding RVOT intervention) (three
interventions)
109 50,821 43,451 60,418
Fenestration device closure (plus at least one additional intervention) 39 53,480 48,161 63,497
ASD or PFO closure (plus at least one additional intervention) 9 57,114 43,846 70,837
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A multivariable linear regression model was developed for
the outcome, procedure-related values, starting with CCC
and including patient and procedural characteristics from
the univariate model. The addition of number of inter-
ventions (R
2 = 73.7 %) and number of interventions and
diagnosis (R
2 = 74.2 %) minimally improved explanation
of the variability in charges, while all other characteristics
added such as case type, age, and admit source did not
result in a signiﬁcant increase in explanatory value.
Catheterization Charge Category and APR-DRG
Relationship
We were able to link 76 % (N = 2,919) of cases performed
as inpatients to an APR-DRG SOI and CMI value. These
values were examined to determine whether they correlated
with CCC, and the ﬁnal results are summarized in Table 5
and Fig. 2. The total number of cases linked to an APR-
DRG value was grouped into the corresponding CCC, and
the median charge for each CCC was calculated. The
weighted mean SOI for CCC 1 (3.3) when compared to
CCC 7 (2.4) demonstrated no relationship between CCC
and SOI subclasses. Furthermore, the percentage of all
cases classiﬁed as SOI subclass 4, the highest SOI subclass,
was 44 % in CCC 1 compared to 2 % in CCC 7. Similarly,
CMI proved to have little association with CCC. Instead of
a direct relationship between geometric mean CMI and
CCC, CCC 1 (5.8) had a higher geometric mean CMI than
any other CCC, including CCC 7 (4.1) (Fig. 2).
Discussion
To more accurately account for the variability of charges in
CHD patients undergoing a catheterization procedure, our
multidisciplinary group developed a metric based on cath-
eterization charges from the reporting and billing database
at Children’s Hospital Boston for ﬁscal years 2008–2010.
The outcome chosen to account for resource utilization was
total procedure-related values, which comprised of proce-
dure codes (CPT with associated charge), supplies, and
recovery-related expenses. Procedure-related values were
chosen in order to exclude charges and aspects of in-hos-
pital care during the episode of care unrelated to the cath-
eterization laboratory. Catheterization cases were deﬁned






RVOT dilation and/or stent and proximal or distal right or left PA angioplasty and/or stent (four or more
interventions)
36 62,001 55,281 69,004
Proximal or distal right or left PA angioplasty and/or stent (excluding RVOT intervention) (four or more
interventions)
198 60,347 50,675 70,345
Category 7
Percutaneous pulmonary valve placement 89 83,095 75,848 90,434
PDA patent ductus arteriosus, RVOT right ventricular outﬂow tract, PA pulmonary artery, ASD atrial septal defect, PFO patent foramen ovale,
VSD ventricular septal defect
Fig. 1 Distribution of cases and associated charges by CCC. The
distribution of catheterization cases by CCC is represented by the
columns, and the calculated median and interquartile range charge for
each CCC is represented by the scatter plot
Table 4 Catheterization charge category distribution
N (%) Median
($)




1 451 (12) 13,880 12,744 15,213 \0.001 0.726
2 1,296 (34) 18,786 16,170 21,628
3 522 (14) 30,869 26,966 34,811
4 497 (13) 35,222 31,368 39,925
5 554 (15) 42,773 36,884 51,695
6 391 (10) 56,926 48,966 67,523
7 89 (2) 83,095 75,848 90,434
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123expert consensus. The procedure types were further
grouped into 7 CCC stratiﬁed by charge outcomes. The
CCC demonstrated a moderately strong explanation of the
variability in outcome charges (R
2 = 72.6 %). Factors
typically associated with resource utilization such as num-
ber of interventions (R
2 = 73.7 %) and number of inter-
ventions and diagnosis (R
2 = 74.2 %) slightly improved
discrimination when added to the CCC.
The APR-DRG diagnostic classiﬁcation system, a
widely used ﬁnancial metric that evaluates resource
intensity and outcomes, is coded based on hospital dis-
charge data and is therefore inadequate in serving as a
prospective predictor of resource utilization. As APR-DRG
is based on the accumulation of a patient’s characteristics
including all cardiac and non-cardiac diagnoses, comor-
bidities, and past procedures, this metric may be less ade-
quate in measuring patient resource utilization than CCC,
which is based on procedure-related charges and modiﬁers
derived from a priori patient and procedural characteristics
reﬂecting the patient’s health status at the time of the
catheterization. In our analysis, geometric mean CMI was
highest in CCC 1, comprised of heart biopsy after trans-
plant, although this was the procedure type with the lowest
associated median charge. This ﬁnding may be due to this
patient population’s signiﬁcant past cardiac diagnoses and
procedures rather than the resource utilization required at
the time of a heart biopsy catheterization. Neither SOI or
CMI demonstrated a relationship with CCC and as SOI and
CMI are intended to capture the ﬁnancial complexity of
patients we expected that these metrics would correlate
with CCC as we have shown CCC measures the variation
in charges and resource utilization for catheterization
procedures reasonably well.
The majority of Medicare and non-Medicare payers
report current use of a system of physician reimbursement
based on the Medicare Resource-Based Relative Value
Scale (RBRVS), with 77 % of private plans based on this
payment system according to an American Medical Asso-
ciation (AMA) survey in 2006 [1, 4, 6]. Physician payment
through the RRBVS system is determined by total relative
value units (RVUs), which are based on physician work,
professional expenses, and professional liability insurance,
and are assigned to procedures identiﬁed by the AMA’s
CPT codes [1, 6]. In the ﬁeld of congenital heart surgery,
CPT codes and subsequently work RVUs were assigned to
81 congenital heart operations in 1993–1994 as they pre-
viously did not exist for these procedures. Jenkins et al. [7]
validated that the work RVU scale for congenital heart
operations correlated reasonably with measuring physician
work and resource consumption.
The catheterization procedure types and CCC developed
by our group are derived from CPT-associated billing
codes similar to the CPT-based RVU system. Our multi-
disciplinary panel believes that our developed metric pre-
sents an easily generalizable tool to assess catheterization
charges among institutions as many institutions bill for
procedures based on CPT codes. Catheterization cases can
be linked from reporting and billing databases to one of the
40 developed procedure types and the corresponding CCC
Table 5 APR-DRG severity of illness and case mix index
Catheterization charge category Cases Median APR-DRG v20 SOI APR-DRG v20 CMI
1 2 3 4 Weighted Geometric
N (%) Charge ($) N (%) N (%) N (%) N (%) Mean SOI Mean CMI
1 119 (4) 13,989 2 (2) 18 (15) 47 (40) 52 (44) 3.3 5.8
2 863 (30) 18,404 78 (9) 278 (32) 270 (31) 237 (27) 2.8 3.4
3 434 (15) 30,301 53 (12) 169 (39) 125 (29) 87 (20) 2.6 3.8
4 456 (16) 35,838 136 (30) 130 (29) 116 (25) 74 (16) 2.3 3.9
5 532 (19) 43,847 16 (3) 208 (39) 207 (39) 101 (19) 2.7 3.8
6 382 (13) 57,692 10 (3) 160 (42) 160 (42) 52 (14) 2.7 3.7
7 85 (3) 82,746 3 (4) 44 (52) 36 (42) 2 (2) 2.4 4.1
CMI case mix index, SOI severity of illness
Fig. 2 APR-DRG CMI and associated charges. Catheterization cases
with an associated APR-DRG value were linked to CMI subclass and
grouped into corresponding CCC to allow for median charge as well
as geometric mean CMI to be calculated by CCC
Pediatr Cardiol (2015) 36:264–273 271
123to calculate the median charge of each CCC at various
institutions. This is especially pertinent as the APR-DRG
system has been found to inaccurately classify patients
admitted for congenital heart surgery, which can present
inaccurate outcome reporting in center comparison [10].
Recently, the CPT-based RVU system’s ability to
accurately reﬂect physician work has been examined and
been found inadequate in several surgical ﬁelds [9, 12].
One concern is whether work RVUs accurately measure
physician work in pediatric procedures as the RBRVS was
developed to estimate work on standard adult Medicare
patients [4]. The CPT-based RVU system assigned to
pediatric CHD catheterization procedures has also been
found to be inadequate in reﬂecting required physician
work in a study by Bergersen et al. [3]. This study con-
cluded that many of the pediatric catheterization CPT
codes did not exist or were deduced from procedures per-
formed in adults [3]. Thus, this system does not adjust for
the variable age range or the variable complexity within
and between catheterization procedures [3]. For instance
within diagnostic catheterizations, CPT codes
(93530–93533), a routine angiogram of an otherwise
healthy patient is reimbursed at a similar rate as an
angiogram for an inpatient infant following surgery
although the resources, length of procedure, and number of
full-time equivalent (FTE) ancillary personnel required
differ signiﬁcantly. Likewise, the CPT code (93580) for an
isolated atrial septal defect (ASD) or patent foramen ovale
(PFO) closure, which is typically a short intervention with
low adverse event rates, has a much higher RVU than
diagnostic catheterizations and is on par with more difﬁcult
procedures such as pulmonary vein dilations [3].
The inadequacies inherent in deriving physician work
and resource utilization from RVU assigned to CPT codes
means our developed metric has similar shortcomings as
those described. This led our group to examine potential
modiﬁers based on a priori patient and procedural charac-
teristics that may further strengthen the metric and account
for these inadequacies. Stratiﬁcation via expert consensus
by the number of interventions of the catheterization pro-
cedure types and the addition of the number of interven-
tions and diagnosis to CCC resulted in a metric that is a
moderately strong predictor of charges. However, our
metric warrants reevaluation, especially in its ability to
measure resource intensity and physician work during a
catheterization. In order to add explanatory value, addi-
tional characteristics may need to be measured and
accounted for such as complexity of care requiring differ-
ent levels of resources from a stafﬁng perspective. Duration
of procedure is a potential characteristic that has been
indicated as an area that the current CPT-based RVU
system does not reimburse appropriately [9, 12].
The development of the procedure types and CCC was
based on catheterization data from a single institution, and
after reevaluation, further validation will be required to
demonstrate our metric is generalizable to cases at different
institutions. The value of absolute hospital charges
assigned to procedure types may vary between institutions
due to the valuation of an interventional procedure CPT
code, hospital location, and local billing patterns; however,
relative hospital charges by catheterization procedure type
and CCC should be generalizable. Attempting comparative
analyses in administrative databases such as the Pediatric
Health Information System (PHIS), an inpatient dataset,
was determined to not be possible because most catheter-
ization cases are considered outpatient procedures. There-
fore, exploration of our hospital ﬁnance data revealed that
less than 50 % of catheterization cases are captured in
PHIS.
The developed procedure type ﬁnancial grouper shows
that it is feasible to create such a predictive model for
catheterization. Studies examining the variation in costs
among institutions and charge methodologies associated
with CHD patients in pediatric cardiology have mostly
focused on surgical management up to this point [5, 7, 11,
15]. However, catheterization procedures for CHD patients
warrant a separate methodology to compare charges, yet no
methodology nor billing standards currently exist. The
inadequacies with the current RBRVS system justiﬁes a
reevaluation of the current billing system and an expanded
set of CPT codes to better capture the variability in age,
complexity, and the procedures types performed for CHD
patients undergoing catheterization.
Conclusion
The results of this study demonstrate that the development
of a procedure type ﬁnancial grouper for CHD catheteri-
zation case types is feasible. The metric developed by our
group, CCC, is a more accurate tool in assessing patient
resource utilization than current ﬁnancial metrics, such as
APR-DRG, case mix index, and severity of illness as both
of these ﬁnancial metrics did not correlate with CCC.
Although CCC is a moderately strong predictor of the
variability in catheterization procedure type charges, fur-
ther work is needed to identify additional patient and
procedural characteristics that inﬂuence resource utiliza-
tion and physician work as they may strengthen the metric.
In the interim, as CCC relies on deﬁning procedures via
CPT codes and catheterization procedures at institutions
are generally billed based on CPT codes, this developed
metric provides an easily generalizable tool to examine
charges at a single point in time, longitudinally, and across
272 Pediatr Cardiol (2015) 36:264–273
123institutions to inform negotiation of prices with health care
reformers.
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